E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/12/2006 in the Prospect News Biotech Daily.

Strides Arcolab, Abdi Ibrahim to set up joint-venture company

By Elaine Rigoli

Tampa, Fla., June 12 - Strides Arcolab Ltd. and Abdi Ibrahim, a Turkish pharmaceutical company, have signed a 50-50 joint venture agreement to introduce a range of specialty pharmaceutical products developed by the company for the Turkish and neighboring markets.

The new company will be called Abdi Strides and will leverage Strides' product pipeline and manufacturing capabilities with Abdi Ibrahim's sales and marketing team in Turkey.

Strides Arcolab is a global pharmaceutical company based in Bangalore, India.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.